InvestorsHub Logo

Whalatane

03/16/22 5:44 PM

#15109 RE: zzaatt #15108

How does someone as smart as you think you are … ride this all the way down from $33 to $11 ?

Hubris …. You’re a wonderful example of hubris

Wife’s renal dept acknowledges the clinical
benefit in using Lupkynis for severe LN .
Problem is it’s currently overpriced on a QALY ( quality adjusted life years ) basis so insurers require patients to fail existing therapies first …. and patients still need to take steriods with it .

Yes they can taper the steroid use faster with Lupkynis then with other therapies …BUT the patients hate the steroids for all the reasons you should know by now .

Any LN therapy that also requires steroid use is prone to patient discontinuing that therapy

If you manage to overcome your hubris then consider those CKD / LN drugs in development that protect kidney function for LN patients without steriods being needed as well

Kiwi

Ganz

03/17/22 10:11 AM

#15110 RE: zzaatt #15108

This clown is still quoting his “wife”, what a tool, hilarious!,